Cargando…
Effectiveness and Safety of Botulinum Toxin Type A in Children with Musculoskeletal Conditions: What Is the Current State of Evidence?
Children with musculoskeletal conditions experience muscle weakness, difficulty walking and limitations in physical activities. Standard treatment includes physiotherapy, casting, and surgery. The use of botulinum toxins appears as a promising treatment on its own, but usually as an adjunct to other...
Autores principales: | Dahan-Oliel, Noémi, Kasaai, Bahar, Montpetit, Kathleen, Hamdy, Reggie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328151/ https://www.ncbi.nlm.nih.gov/pubmed/22548088 http://dx.doi.org/10.1155/2012/898924 |
Ejemplares similares
-
Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions
por: Elfassy, Caroline, et al.
Publicado: (2023) -
Management of common elective paediatric orthopaedic conditions during the COVID-19 pandemic: the Montreal experience
por: Keshet, Doron, et al.
Publicado: (2020) -
Use of botulinum toxin in musculoskeletal pain
por: Singh, Jasvinder A
Publicado: (2013) -
The Effect of Heparan Sulfate Application on Bone Formation during Distraction Osteogenesis
por: Gdalevitch, Marie, et al.
Publicado: (2013) -
Functional Gains in Children With Spastic Hemiplegia Following a Tendon Achilles Lengthening Using Computerized Adaptive Testing—A Pilot Study
por: Saleh, Eli, et al.
Publicado: (2018)